Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 21;47(9):4736-4750.
doi: 10.1093/nar/gkz230.

Structural characterization of B. subtilis m1A22 tRNA methyltransferase TrmK: insights into tRNA recognition

Affiliations

Structural characterization of B. subtilis m1A22 tRNA methyltransferase TrmK: insights into tRNA recognition

Clément Dégut et al. Nucleic Acids Res. .

Abstract

1-Methyladenosine (m1A) is a modified nucleoside found at positions 9, 14, 22 and 58 of tRNAs, which arises from the transfer of a methyl group onto the N1-atom of adenosine. The yqfN gene of Bacillus subtilis encodes the methyltransferase TrmK (BsTrmK) responsible for the formation of m1A22 in tRNA. Here, we show that BsTrmK displays a broad substrate specificity, and methylates seven out of eight tRNA isoacceptor families of B. subtilis bearing an A22. In addition to a non-Watson-Crick base-pair between the target A22 and a purine at position 13, the formation of m1A22 by BsTrmK requires a full-length tRNA with intact tRNA elbow and anticodon stem. We solved the crystal structure of BsTrmK showing an N-terminal catalytic domain harbouring the typical Rossmann-like fold of Class-I methyltransferases and a C-terminal coiled-coil domain. We used NMR chemical shift mapping to drive the docking of BstRNASer to BsTrmK in complex with its methyl-donor cofactor S-adenosyl-L-methionine (SAM). In this model, validated by methyltransferase activity assays on BsTrmK mutants, both domains of BsTrmK participate in tRNA binding. BsTrmK recognises tRNA with very few structural changes in both partner, the non-Watson-Crick R13-A22 base-pair positioning the A22 N1-atom close to the SAM methyl group.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
BsTrmK methylates a variety of B. subtilis tRNAs. Autoradiograms of chromatograms of P1 hydrolysates of [α32P]ATP-labelled T7-transcripts of B. subtilis tRNAs incubated during 15 minutes with SAM and increasing amounts of purified BsTrmK (from 0 to 600 nM). The sequences of the tRNAs tested as substrates are drawn above and below the autoradiograms. (A) tRNASer, (B) tRNAHis, (C) tRNATyr, (D) tRNACys, (E) tRNAGln, (F) tRNAGlu, (G) tRNALeu, (H) tRNAGly.
Figure 2.
Figure 2.
BsTrmK MTase assays with B. subtilis tRNAs mutated at position 13, and with tRNAHis altered in the T-loop or in the anticodon stem-loop. [α32P]ATP-labelled T7-transcripts of mutated tRNASer (A) or tRNAHis (B–D) of B. subtilis were incubated during 15 min with SAM and increasing amounts of purified BsTrmK. P1 hydrolysates were separated by thin layer chromatography. After autoradiography the radioactivity of the spots corresponding to pA and pm1A was measured by scintillation counting. The fraction of m1A obtained was plotted versus the corresponding BsTrmK concentration in the reaction mixture (A) for mutants of tRNASer at position 13, (B) for mutants of tRNAHis at position 13, (C) for variants of tRNAHis in the T-loop, (D) for variants of tRNAHis in the anticodon stem-loop. (E) Summary on the tRNASer structure of the determinants required for BsTrmK MTase activity: the length of the variable region (in green) is not important, the base-pair A22–N13 (in red) involves a purine at position 13, an intact 3D structure is necessary notably at the level of the T-loop (in orange) and anticodon stem (in orange).
Figure 3.
Figure 3.
Crystal structure of BsTrmK. SAM was modelled in the catalytic center of BsTrmK by superposing the BsTrmK structure with that of its ortholog from S. pneumoniae (PDB code 3KU1). It is represented as sticks. (A) Ribbon representation of BsTrmK, α-helices are coloured in red whereas β-strands are in yellow. (B) Location on the structure of BsTrmK of conserved residues, the sequence of B. subtilis TrmK was aligned with those of the representative members of the COG2384 family, (C) Representation of electrostatic surface potentials of TrmK, Positive charges are in blue whereas negative ones are in red with the maximum color saturation corresponding to −5 kT/e (red) and +5 kT/e (blue). The figure was prepared with the APBS PyMOL plug-in (52) and pdb2pqr webserver (53). (D) Normal mode analysis of BsTrmK showing the mobility of the last part of the C-terminal domain. The mean mobility of residues in the six first non-trivial computed normal modes is plotted as a function of the BsTrmK residue number.
Figure 4.
Figure 4.
Interaction of BstRNASer with BsTrmK/SAH deciphered by NMR. (A) The presence of post-transcriptional modifications in BsTrmK substrate alters the MTase activity of BsTrmK. Sequence of B. subtilis tRNASer produced in vivo in E. coli showing post-transcriptional modifications incorporated by E. coli modifying enzymes. (B) Kinetic and enzymatic parameters of BsTrmK measured for BstRNASer bearing (tRNASerin vivo) or not bearing (tRNASerin vitro) post-transcriptional modifications. Confidence intervals at 90% are indicated in parenthesis. An unmodified BstRNASer was chosen to study the interaction of BstRNASer with BsTrmK given that BstRNASer prepared in vitro is a better substrate. (C) Selected regions from the superposition of three 2D 1H–15N TROSY experiments, showing amide groups of BsTrmK, alone in black, with the SAH in red and with SAH and BstRNASer in green (D) NMR chemical shift mapping of BstRNASer binding reported onto the molecular surface of BsTrmK. Pink residues are those that disappeared upon addition of tRNA, residues that experience, upon tRNA binding, NMR chemical shift variations between 0.02 and 0.04 ppm are in orange and larger than 0.04 ppm are in red. Residues in grey are residues for which NMR chemical shift variations could not be measured either because it is a proline residue or a residue for which the NMR signal has disappeared upon SAH addition.
Figure 5.
Figure 5.
Model of the BsTrmK/SAM/BstRNASer complex based on the NMR chemical shift mapping and validated by MTase activity of BsTrmK variants mutated at the binding interface with tRNA. (A) Top-scoring structure from HADDOCK docking guided by the NMR chemical shift mapping of the BstRNASer binding on BsTrmK, the D-arm is drawn in orange, the G13-A22 base pair is in red sticks, the SAM on the BsTrmK catalytic pocket is represented as sticks, (B) The base-pair G13-A22 is in close proximity to the SAM-methyl donor in the model (C) MTase activity of BsTrmK variants mutated in the tRNA binding interface (D) Positions of the mutations on BsTrmK/SAM/BstRNASer complex, the BstRNASer is represented with the same color code as that used in Figure 2E, the tRNA elements crucial for BsTrmK activity are in red and orange (E) Profile view of the model.

References

    1. Boccaletto P., Machnicka M.A., Purta E., Piatkowski P., Baginski B., Wirecki T.K., de Crecy-Lagard V., Ross R., Limbach P.A., Kotter A. et al. .. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2018; 46:D303–D307. - PMC - PubMed
    1. Oerum S., Degut C., Barraud P., Tisne C.. m1A Post-Transcriptional modification in tRNAs. Biomolecules. 2017; 7:E20. - PMC - PubMed
    1. Grosjean H., Constantinesco F., Foiret D., Benachenhou N.. A novel enzymatic pathway leading to 1-methylinosine modification in Haloferax volcanii tRNA. Nucleic Acids Res. 1995; 23:4312–4319. - PMC - PubMed
    1. Roovers M., Wouters J., Bujnicki J.M., Tricot C., Stalon V., Grosjean H., Droogmans L.. A primordial RNA modification enzyme: the case of tRNA (m1A) methyltransferase. Nucleic Acids Res. 2004; 32:465–476. - PMC - PubMed
    1. Kempenaers M., Roovers M., Oudjama Y., Tkaczuk K.L., Bujnicki J.M., Droogmans L.. New archaeal methyltransferases forming 1-methyladenosine or 1-methyladenosine and 1-methylguanosine at position 9 of tRNA. Nucleic Acids Res. 2010; 38:6533–6543. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources